OpenURL Connection Search

Select item for more details and to access through your institution.

DIAGNOSIS OF PANCREATIC CANCER USING DUPAN - 2 MONOCLONAL ANTIBODY.
Published in:
HPB Surgery, 1990, v. 2, p. 483
By:
- Opocher, E.;
- Spina, G. P.;
- Santambrogio, R.;
- Cucchiaro, G.;
- Vignati, L.;
- Tarolo, G. L.;
- Marelli, F.;
- Borzio, F.;
- Pedersoli, P.
Publication type:
Article
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 160, doi. 10.1111/apt.13821
By:
- Petta, S.;
- Cabibbo, G.;
- Barbara, M.;
- Attardo, S.;
- Bucci, L.;
- Farinati, F.;
- Giannini, E. G.;
- Tovoli, F.;
- Ciccarese, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Virdone, R.;
- Marra, F.;
- Felder, M.;
- Morisco, F.;
- Benvegnù, L.
Publication type:
Article
Years of life that could be saved from prevention of hepatocellular carcinoma.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 7, p. 814, doi. 10.1111/apt.13554
By:
- Cucchetti, A.;
- Trevisani, F.;
- Bucci, L.;
- Ravaioli, M.;
- Farinati, F.;
- Giannini, E. G.;
- Ciccarese, F.;
- Piscaglia, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Maida, M.;
- Felder, M.;
- Morisco, F.;
- Gasbarrini, A.;
- Gemini, S.;
- Foschi, F. G.
Publication type:
Article
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 3, p. 385, doi. 10.1111/apt.13485
By:
- Bucci, L.;
- Garuti, F.;
- Camelli, V.;
- Lenzi, B.;
- Farinati, F.;
- Giannini, E. G.;
- Ciccarese, F.;
- Piscaglia, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Maida, M.;
- Felder, M.;
- Morisco, F.;
- Gasbarrini, A.;
- Gemini, S.;
- Foschi, F. G.
Publication type:
Article
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 4, p. 493, doi. 10.1111/j.1365-2036.2009.04198.x
By:
- GIANNINI, E. G.;
- BODINI, G.;
- CORBO, M.;
- SAVARINO, V.;
- RISSO, D.;
- DI NOLFO, M. A.;
- DEL POGGIO, P.;
- BENVEGNÙ, L.;
- FARINATI, F.;
- ZOLI, M.;
- BORZIO, F.;
- CATURELLI, E.;
- CHIARAMONTE, M.;
- TREVISANI, F.
Publication type:
Article

Found: 5

DIAGNOSIS OF PANCREATIC CANCER USING DUPAN - 2 MONOCLONAL ANTIBODY.

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.

Years of life that could be saved from prevention of hepatocellular carcinoma.

Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.

Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.